Preliminary evidence for therapeutic impact of intravesical glucosamine on protamine sulfate and potassium chloride-induced bladder overactivity in rat model-Reference-Cited by-同舟云学术

Preliminary evidence for therapeutic impact of intravesical glucosamine on protamine sulfate and potassium chloride-induced bladder overactivity in rat model

Published:2024-07-11 Issue:1 Volume:42 Page:
ISSN:1433-8726
Container-title:World Journal of Urology
language:en
Short-container-title:World J Urol

Author:

Lu Shing-Hwa^ORCID,Yun Tien-Fu,Kou Yu Ru,Chang Yi-Ping

Funder

Taipei Veterans General Hospital

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1007/s00345-024-05100-3.pdf

Reference33 articles.

1. Eapen RS, Radomski SB (2016) Review of the epidemiology of overactive bladder. Res Rep Urol 8:71–76. https://doi.org/10.2147/rru.S102441

2. Peyronnet B, Mironska E, Chapple C, Cardozo L, Oelke M, Dmochowski R, Amarenco G, Gamé X, Kirby R, Van Der Aa F, Cornu J-N (2019) A Comprehensive Review of overactive bladder pathophysiology: on the way to tailored treatment. Eur Urol 75:988–1000. https://doi.org/10.1016/j.eururo.2019.02.038

3. Chapple CR, Cardozo L, Steers WD, Govier FE (2006) Solifenacin significantly improves all symptoms of overactive bladder syndrome. Int J Clin Pract 60:959–966. https://doi.org/10.1111/j.1742-1241.2006.01067.x

4. Edmondson SD (2017) 7.20 - β3-AR agonists for the treatment of overactive bladder. In: Chackalamannil S, Rotella D, Ward SE (eds) Comprehensive Medicinal Chemistry III. Elsevier, Oxford, pp 714–737. https://doi.org/10.1016/B978-0-12-409547-2.12788-X

5. Chuang YC, Liu SP, Lee KS, Liao L, Wang J, Yoo TK, Chu R, Sumarsono B (2019) Prevalence of overactive bladder in China, Taiwan and South Korea: results from a cross-sectional, population-based study. Low Urin Tract Symptoms 11:48–55. https://doi.org/10.1111/luts.12193